Is anti-platelet therapy interruption a real clinical issue? Its implications in dentistry and particularly in periodontics.

Autor: Kumar AJ; Department of Periodontics, Sri Sai College of Dental Surgery, Vikarabad, Andhra Pradesh, India., Kumari MM, Arora N, Haritha A
Jazyk: angličtina
Zdroj: Journal of Indian Society of Periodontology [J Indian Soc Periodontol] 2009 Sep; Vol. 13 (3), pp. 121-5.
DOI: 10.4103/0972-124X.60223
Abstrakt: The use of anti-platelet therapy has reduced the mortality and morbidity of cardiovascular disease remarkably. A considerable number of patients presenting before a dentist or periodontist give a history of anti-platelet therapy. A clinical dilemma whether to discontinue the anti-platelet therapy or continue the same always confronts the practitioner. Diverse opinions exist regarding the management of such patients. While one group of researchers advise continuation of anti-platelet therapy rather than invite remote, but possible, thromboembolic events, another group encourages discontinuation for variable periods. This study aims at reviewing the current rationale of anti-platelet therapy and the various options available to a clinician, with regard to the management of a patient under anti-platelet therapy. Current recommendations and consensus favour no discontinuation of anti-platelet therapy. This recommendation, however, comes with a rider to use caution and consider other mitigating factors as well. With a large number of patients giving a history of anti-platelet therapy, the topic is of interest and helps a clinician to arrive at a decision.
Databáze: MEDLINE